GSK, Vir’s COVID antibody put on ice as BA.2 subvariant takes hold
GSK, Vir’s COVID antibody put on ice as BA.2 subvariant [...]
GSK, Vir’s COVID antibody put on ice as BA.2 subvariant [...]
BioNTech CEO’s pay fell last year, but he’s still a [...]
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk [...]
Sanofi, Regeneron score fast FDA review for Dupixent in eosinophilic [...]
Alnylam’s Onpattro follow-on delayed thanks to manufacturing holdup at FDA [...]
ACC: Lexicon hopes sotaglifozin cardio data will set its drug [...]
Viatris, after closing massive West Virginia plant, sells it for [...]
Pfizer asks hourly staffers to return overpayments in aftermath of [...]
Bristol Myers CEO Caforio takes pay cut as ‘human capital’ [...]
After pocketing $18.9M, Seagen’s Clay Siegall could reclaim spot among [...]